Pharmaceuticals Market Research Reports

Pharmaceutical Market

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this industry. The pharmaceutical market, valued as a multi-billion dollar market, is undoubtedly the largest revenue generator for the life sciences industry.

The pharmaceutical industry can be divided into numerous market segments based on the different therapeutic areas and applications. The largest segment, the market for cardiovascular drugs, records huge sales every year. The rising world population, rapid ageing of the same, and an increased prevalence of diseases are the major factors driving growth of this industry. The recent breakthroughs in proteomics and genomics have led to the development of modernized approaches to drug discovery and development in the industry, for the possibility of newer, advanced, and more sophisticated therapies and drugs. Developments in biotechnology research have led to introduction of advanced therapies involving biopharmaceuticals, regenerative medicine, stem cells, etc. These new age therapies and products have caused ease of treatment procedures and enabled speedy recovery from various disorders. Technological growth in such interdisciplinary fields has opened up new arenas in drug discovery, drug delivery, and life sciences research.
Certain incurable diseases like cancer and AIDS, which are therapeutic areas of prime concern for scientists and doctors all over the world, depict immense growth potential for the pharmaceutical industry in the future. Surfacing of newer diseases and therefore, the rising requirement of newer drug delivery methods, explains the greater than before importance of research and development activities in the industry. Industry leaders now generously allocate around 20% of their turnover to R&D to allot the finest instruments and manpower for their use. This has helped them maintain a competitive edge over other players in the market. However, the high costs of R&D, shorter product life cycles, and trouble producing a ‘best-seller’ has introduced the trend of mergers, acquisitions, strategic alliances, and most importantly, outsourcing in the industry. Numerous companies have been entering into global tie-ups and collaborations pooling and utilizing their resources for R&D and new product development in almost all areas. With this ongoing and rapidly developing trend, countries have shown great interest in encouraging investments in developing R&D and manufacturing facilities by public funding and tax exemptions.

The industry, however, faces certain major challenges, one of them being the imbalance between the rate of introduction of novel drugs and that of patent expiry of the already existing brands. Rising research investments, development of better infrastructure, efficient allocation of resources, etc. are some of the measures adopted by players to cope with this problem. Stringent governmental regulation of this market in certain countries also sometimes restricts growth and causes loss of potential opportunities. However, certain regulatory measures such as patent protection for novel and blockbuster drugs helps manufacturers recover the massive investment costs incurred during the discovery, development, and commercialization of products. On the other hand, there are generic versions of drugs which are available at minimal prices as compared to patented drugs. These address the issue of affordability of drugs to the lower income groups.
Presently, the global pharmaceutical market is dominated by the United States. But huge double-digit growth rates are being observed in developing countries too, China and India being the best examples. This is mainly due to a large number of established multinational pharmaceutical companies outsourcing their research and manufacturing activities to these countries, owing to the favorable cost factor, modernized infrastructure, and a large and skilled base of scientifically knowledgeable manpower. Also, other emerging regional markets like Brazil, Russia, Germany, France, Spain, etc., continue to show tremendous growth in the pharmaceutical sector.

This section on pharmaceutical industry research consists of market research reports on its various segments like Cardiovascular drugs, Anesthesia drugs, Drug Discovery and Development, Dentistry, Dermatology, Blood and blood products, Clinical Diagnostics,  In vitro/Molecular Diagnostics, Radiology, Oncology, Dietary Supplements, Vaccines, Generics, and OTC drugs. The reports presented in this section include in-depth industry analysis involving major market players, latest market trends, new product developments, growth drivers, growth restrainers, market forecasts, and so on.

View More
TITLE Actions
Global Microplates Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
Published in Apr 2019 | US $ 3480 Onwards | By Global Info Research

Scope of the Report: The worldwide market for Microplates is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) ...

Global Cooling Paste Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
Published in Apr 2019 | US $ 3480 Onwards | By Global Info Research

Scope of the Report: The worldwide market for Cooling Paste is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research...

Global Human Factor IX Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
Published in Apr 2019 | US $ 3480 Onwards | By Global Info Research

Scope of the Report: The worldwide market for Human Factor IX is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global I...

Global Parkinson's Disease Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Published in Apr 2019 | US $ 3480 Onwards | By Global Info Research

Scope of the Report: The global Parkinson's Disease Therapeutics market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. The Asia-Pacific...

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 3500 Onwards | By Global Markets Direct

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019 Summary According to the recently published report 'Survival Motor Neuron Protein - Pipeline Review, H1 ...

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 3500 Onwards | By Global Markets Direct

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H1 2019 Summary Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Respiratory syncytial virus G protein is a ...

Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygenase or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 4.1.2.30) - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 3500 Onwards | By Global Markets Direct

Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygenase or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 4.1.2.30) - Pipeline Review, H1 ...

Smoothened Homolog (Protein Gx or SMO) - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 3500 Onwards | By Global Markets Direct

Smoothened Homolog (Protein Gx or SMO) - Pipeline Review, H1 2019 Summary According to the recently published report 'Smoothened Homolog - Pipeline Review, H1 2019'; Smoothened Homolog (Protein Gx or SMO) pipel...

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 3500 Onwards | By Global Markets Direct

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H1 2019 Summary Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Integrin beta-3 (?3) or CD61 is...

5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 3500 Onwards | By Global Markets Direct

5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Pipeline Review, H1 2019 Summary 5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) pipeline Target constitutes close to ...

Angiopoietin 1 Receptor (Endothelial Tyrosine Kinase or Tunica Interna Endothelial Cell Kinase or Tyrosine Kinase With Ig And EGF Homology Domains 2 or Tyrosine Protein Kinase Receptor TEK or Tyrosine Protein Kinase Receptor TIE 2 or p140 TEK or CD202b or TIE2 or TEK or EC 2.7.10.1) - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 3500 Onwards | By Global Markets Direct

Angiopoietin 1 Receptor (Endothelial Tyrosine Kinase or Tunica Interna Endothelial Cell Kinase or Tyrosine Kinase With Ig And EGF Homology Domains 2 or Tyrosine Protein Kinase Receptor TEK or Tyrosine Protein Kinase Receptor TIE 2 or p1...

Mitogen Activated Protein Kinase 8 (c Jun N Terminal Kinase 1 or JNK 46 or Stress Activated Protein Kinase JNK1 or Stress Activated Protein Kinase 1c or MAPK8 or EC 2.7.11.24) - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 3500 Onwards | By Global Markets Direct

Mitogen Activated Protein Kinase 8 (c Jun N Terminal Kinase 1 or JNK 46 or Stress Activated Protein Kinase JNK1 or Stress Activated Protein Kinase 1c or MAPK8 or EC 2.7.11.24) - Pipeline Review, H1 2019 Summary ...

Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 3500 Onwards | By Global Markets Direct

Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) - Pipeline Review, H1 2019 Summary Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto ...

Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog or CASP8 or EC 3.4.22.61) - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 3500 Onwards | By Global Markets Direct

Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog or CASP8 or EC 3.4.22.61) - Pipeli...

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 3500 Onwards | By Global Markets Direct

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019 Summary Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Neuronal acetylcholine receptor subunit alpha-7 is a protei...

Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 3500 Onwards | By Global Markets Direct

Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H1 2019 Summary ...

Optic Neuropathy - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 2000 Onwards | By Global Markets Direct

Optic Neuropathy - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Optic Neuropathy - Pipeline Review, H1 2019, provides an overview of the O...

Blepharitis - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 2000 Onwards | By Global Markets Direct

Blepharitis - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Blepharitis - Pipeline Review, H1 2019, provides an overview of the Blepharitis...

Viral Conjunctivitis - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 2000 Onwards | By Global Markets Direct

Viral Conjunctivitis - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Viral Conjunctivitis - Pipeline Review, H1 2019, provides an overview ...

Hypoglycemia - Pipeline Review, H1 2019
Published in Apr 2019 | US $ 2000 Onwards | By Global Markets Direct

Hypoglycemia - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypoglycemia - Pipeline Review, H1 2019, provides an overview of the Hypoglyce...

We are on:

Need Help?